公开(公告)号：US20240010732A1

公开(公告)日：2024-01-11

申请号：US18364312

申请日：2023-08-02

Applicant: Genentech, Inc.

Inventor： Ying YANG ,  Sreedhara ALAVATTAM

IPC: C07K16/28 ,  A61K39/395

CPC classification number: C07K16/2827 ,  A61K39/39591 ,  A61K2039/505 ,  C07K2317/76 ,  C07K2317/41

Abstract: The invention provides stable aqueous pharmaceutical formulations comprising an anti-PDL1 antibody. The invention also provides methods for making such formulations and methods of using such formulations.

公开(公告)号：US20250145717A1

公开(公告)日：2025-05-08

申请号：US18900229

申请日：2024-09-27

Applicant: Genentech, Inc.

Inventor： Ying YANG ,  Sreedhara ALAVATTAM

IPC: C07K16/28 ,  A61K39/00 ,  A61K39/395

Abstract: The invention provides stable aqueous pharmaceutical formulations comprising an anti-PDL1 antibody. The invention also provides methods for making such formulations and methods of using such formulations.

公开(公告)号：US20160319022A1

公开(公告)日：2016-11-03

申请号：US15081785

申请日：2016-03-25

Applicant: Genentech, Inc.

Inventor： Ying YANG ,  Sreedhara ALAVATTAM

IPC: C07K16/28 ,  A61K39/395

CPC classification number: C07K16/2827 ,  A61K39/39591 ,  A61K2039/505 ,  C07K2317/41 ,  C07K2317/52 ,  C07K2317/76

Abstract: The invention provides stable aqueous pharmaceutical formulations comprising an anti-PDL1 antibody. The invention also provides methods for making such formulations and methods of using such formulations.

Abstract translation: 本发明提供包含抗PDL1抗体的稳定的含水药物制剂。 本发明还提供了制备这些制剂的方法和使用这些制剂的方法。

公开(公告)号：US20210221892A1

公开(公告)日：2021-07-22

申请号：US17101966

申请日：2020-11-23

Applicant: Genentech, Inc.

Inventor： Ying YANG ,  Sreedhara ALAVATTAM

IPC: C07K16/28 ,  A61K39/395

Abstract: The invention provides stable aqueous pharmaceutical formulations comprising an anti-PDL1 antibody. The invention also provides methods for making such formulations and methods of using such formulations.